0001562180-19-004100.txt : 20190730
0001562180-19-004100.hdr.sgml : 20190730
20190730162929
ACCESSION NUMBER: 0001562180-19-004100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190729
FILED AS OF DATE: 20190730
DATE AS OF CHANGE: 20190730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Avagliano Mark
CENTRAL INDEX KEY: 0001783503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 19985830
MAIL ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-07-29
false
0001560241
G1 Therapeutics, Inc.
GTHX
0001783503
Avagliano Mark
C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR.
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK
NC
27709
false
true
false
false
Chief Business Officer
Stock Option (Right to Buy)
25.72
2019-07-29
4
A
false
300000.00
0.00
A
2029-07-29
Common Stock
300000.00
300000.00
D
The shares underlying this option vested as to 25% of the shares on July 29, 2020, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
/s/ James Stillman Hanson, attorney-in-fact
2019-07-30